PTEN Promoter Methylation And Expression In Endometrial Cancer Tissues

References

• Stavropoulos A , VarrasM , VasilakakiTet al. Expression of p53 and PTEN in human primary endometrial carcinomas: clinicopathological and immunohistochemical analysis and study of their concomitant expression. Oncol. Lett.17, 4575–4589 (2019).
   PubMed Web of Science ®Google Scholar
• Nagashima M , MiwaN , HirasawHet al. Genome-wide DNA methylation analysis in obese women predicts an epigenetic signature for future endometrial cancer. Sci. Rep.9, 6469–6472 (2019).
   PubMed Web of Science ®Google Scholar
• Rizzo S , FemiaM , BuscarinoVet al. Endometrial cancer: an overview of novelties in treatment and related imaging keypoints for local staging. Cancer Imaging18(45), 12–20 (2018).
   PubMedGoogle Scholar
• Chen J , ShaoR , ChenC. Possible therapeutic implication of PD-L1/PD-1 axis in endometrial cancer. J. Solid Tumors5(1), 7 (2015).
   Google Scholar
• Yazdani S , BouzariZ , Abedisamakous M , Naeimirad M. Epidemiology of endometrial cancer in North of Iran. Basic Clin. Cancer Res.8(4), 4 (2016).
   Google Scholar
• Azizi M , TehraniGA. Evaluation of promoter hypermethylation of tumor-suppressor genes p14 and p16 in Iranian endometrial carcinoma patients. Middle East J. Cancer8(4), 37–41 (2017).
   Google Scholar
• Trimarchi MP , YanP , GrodenJ , BundschuhR , GoodfellowPJ. Identification of endometrial cancer methylation features using combined methylation analysis methods. PLoS One17, 90111–90117 (2017).
   Google Scholar
• Yanokura M , BannoK , SusumuNet al. Hypermethylation in the p16 promoter region in the carcinogenesis of endometrial cancer in Japanese patients. Anticancer Res.26, 851–856 (2006).
   PubMed Web of Science ®Google Scholar
• Maehama T , DixonJE. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem.273(22), 13375–13378 (1998).
   PubMed Web of Science ®Google Scholar
• Hettinger K , VikhanskayaF , PohM , LeeM , de BelleI , ZhangJet al. c-Jun promotes cellular survival by suppression of PTEN. Cell Death Differ.14(2), 218–229 (2007).
   PubMed Web of Science ®Google Scholar
• Yazdani Y , FarazmandfarT , AzadehH , ZekavatianZ. The prognostic effect of PTEN expression status in colorectal cancer development and evaluation of factors affecting it: miR-21 and promoter methylation. J. Biomed. Sci.23, 9 (2016).
   PubMed Web of Science ®Google Scholar
• Freeman DJ , LiAG , WeiG , LiH-H , KerteszN , LescheRet al. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell3, 117–130 (2003).
   PubMed Web of Science ®Google Scholar
• Benitez JA , MaJ , D’AntonioMet al. PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3. Nat. Commun.8, 15 (2017).
   PubMed Web of Science ®Google Scholar
• Qi Q , LingY , ZhuMet al. Promoter region methylation and loss of protein expression of PTEN and significance in cervical cancer. Biomed.Rep.2, 653–658 (2014).
   PubMedGoogle Scholar
• Kang Y-H , LeeHS , KimWH. Promoter methylation and silencing of PTEN in gastric carcinoma. Lab. Invest.82, 285–291 (2002).
   PubMed Web of Science ®Google Scholar
• Soria J-C , LeeH-Y , LeeJIet al. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation. Clin. Cancer Res.8, 1178–1184 (2002).
   PubMed Web of Science ®Google Scholar
• Geybels MS , FangM , WrightJLet al. PTEN loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profiles. Oncotarget8(48), 84338–84348 (2017).
   PubMedGoogle Scholar
• Roh MR , GuptaS , ParkK-Het al. Promoter methylation of PTEN is a significant prognostic factor in melanoma survival. J. Invest. Dermatol.136(5), 1002–1011 (2016).
   PubMed Web of Science ®Google Scholar
• Salvesen HB , StefanssonI , KretzschmarEIet al. Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression. Int. J. Oncol.25, 1615–1623 (2004).
   PubMed Web of Science ®Google Scholar
• Brandmaier A , HouS-Q , ShenWH. Cell cycle control by PTEN. J. Mol. Biol.429(15), 2265–2277 (2017).
   PubMed Web of Science ®Google Scholar
• Banno K , KisuI , YanokuraMet al. Biomarkers in endometrial cancer: possible clinical applications (review). Oncol. Lett.3, 1175–1180 (2012).
   PubMed Web of Science ®Google Scholar
• Misra S , GhoshG , ChowdhurySG , KarmakarP. Non-canonical function of nuclear PTEN and its implication on tumorigenesis. DNA Repair (Amst)107, doi:10.1016/j.dnarep.2021.103197 (2021).
   PubMed Web of Science ®Google Scholar
• Salvesen HB , StefanssonI , KretzschmarEI , GruberP , MacDonaldND , RyanAet al. Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression. Int. J. Oncol.25(6), 1615–1623 (2004).
   PubMed Web of Science ®Google Scholar
• Sarmadi S , Izadi-MoodN , SotoudehK , TavangarSM. Altered PTEN expression; a diagnostic marker for differentiating normal, hyperplastic and neoplastic endometrium. Diagn. Pathol.4(41), 6 (2009).
   PubMedGoogle Scholar
• Roh MR , GuptaS , ParkK-H , ChungKY , LaussM , FlahertyKTet al. Promoter methylation of PTEN is a significant prognostic factor in melanoma survival. J. Invest. Dermatol.136(5), 1002–1011 (2016).
   PubMed Web of Science ®Google Scholar
• Khan S , KumagaiT , VoraJ , BoseN , SehgalI , KoefflerPHet al. PTEN promoter is methylated in a proportion of invasive breast cancers. Int. J. Cancer112(3), 407–410 (2004).
   PubMed Web of Science ®Google Scholar
• Yi T , SongY , ZuoL , WangS , MiaoJ. LINC00470 stimulates methylation of PTEN to facilitate the progression of endometrial cancer by recruiting DNMT3a through MYC. Front. Oncol.11, doi:10.3389/fonc.2021.646217 (2021).
   Web of Science ®Google Scholar
• Chen Z , CheQ , JiangF-Z , WangH-H , WangF-Y , LiaoYet al. Piwil1 causes epigenetic alteration of PTEN gene via upregulation of DNA methyltransferase in type I endometrial cancer. Biochem. Biophys. Res. Commun.463(4), 876–880 (2015).
   PubMed Web of Science ®Google Scholar
• Ramadan A , HashimM , AbouzidA , SwellamM. Clinical impact of PTEN methylation status as a prognostic marker for breast cancer. J. Genet. Eng. Biotechnol.19(1), 1–11 (2021).
   PubMed Web of Science ®Google Scholar
• Soria J-C , LeeH-Y , LeeJI , WangL , IssaJ-P , KempBLet al. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation. Clin. Cancer Res.8(5), 1178–1184 (2002).
   PubMed Web of Science ®Google Scholar
• Kang Y-H , LeeHS , KimWH. Promoter methylation and silencing of PTEN in gastric carcinoma. Lab. Invest.82(3), 285–291 (2002).
   PubMed Web of Science ®Google Scholar
• Hou P , JiM , XingM. Association of PTEN gene methylation with genetic alterations in the phosphatidylinositol 3-kinase/AKT signaling pathway in thyroid tumors. Cancer113(9), 2440–2447 (2008).
   PubMed Web of Science ®Google Scholar
• Li D , FengJ , WuT , WangY , SunY , RenJet al. Long intergenic noncoding RNA HOTAIR is overexpressed and regulates PTEN methylation in laryngeal squamous cell carcinoma. Am. J. Pathol.182(1), 64–70 (2013).
   PubMed Web of Science ®Google Scholar
• Mirmohammadsadegh A , MariniA , NambiarSet al. Epigenetic silencing of the PTEN gene in melanoma. Cancer Res.66(13), 6546–6552 (2006).
   PubMed Web of Science ®Google Scholar
• Yamaguchi S , AsanomaK , TakaoTet al. Homeobox gene HOPX is epigenetically silenced in human uterine endometrial cancer and suppresses estrogen-stimulated proliferation of cancer cells by inhibiting serum response factor. Int. J. Cancer124, 2577–2588 (2009).
   PubMed Web of Science ®Google Scholar
• Zhang H-Y , LiangF , JiaZ-L , SongS-T , JiangZ-F. PTEN mutation, methylation and expression in breast cancer patients. Oncol. Lett.6, 161–168 (2013).
   PubMed Web of Science ®Google Scholar
• Goel A , ArnoldCN , NiedzwieckiDet al. Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers. Cancer Res.64, 3014–3021 (2004).
   PubMed Web of Science ®Google Scholar
• Nero C , CiccaroneF , PietragallaA , ScambiaG. PTEN and gynecological cancers. Cancers11(1458), 17 (2019).
   Google Scholar
• Zuberi M , MirR , DholariyaSet al. RASSF1 and PTEN promoter hypermethylation influences the outcome in epithelial ovarian cancer. Clin. Ovarian Other Gynecol. Malig.7, 6 (2015).
   Google Scholar